Kidney disease drug combo trial halted early
NCT ID NCT04743739
Summary
This study aimed to find out if combining two drugs (rituximab and cyclosporine) works better than using rituximab alone for treating idiopathic membranous nephropathy, a kidney disease that causes protein loss in urine. The trial involved 12 participants with this condition and compared remission rates over two years. The study was terminated early, so full results aren't available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC MEMBRANOUS NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Luhe Hospital, Capital Medical University
Beijing, Beijing Municipality, 101149, China
-
Beijing Tongren Hospital， Capital Medical University
Beijing, Beijing Municipality, 100730, China
-
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100037, China
-
Nanyang Nanshi Hospital, Henan University
Nanyang, Henan, 473065, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
-
The Seventh Affiliated Hospital, Sun Yat-sen University
Shenzhen, Shenzhen, China
Conditions
Explore the condition pages connected to this study.